Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance

View through CrossRef
SummaryGlucagon‐like peptide 1 plays a role in glucose regulation. Sleep disturbances (obstructive sleep apnea, insufficient or poor sleep quality) have been shown to adversely affect glucose metabolism. This study aimed to explore the relationship between sleep and glucagon‐like peptide 1 regulation in patients with abnormal glucose tolerance. Seventy‐one adults with haemoglobin A1c levels between 5.7% and < 6.5% and no history of diabetes participated. Habitual sleep duration and efficiency were obtained from 7‐day actigraphy recordings. Obstructive sleep apnea was assessed using an overnight home monitor. Glucagon‐like peptide 1 levels were measured during a 75‐g glucose tolerance. The area under the curve of glucagon‐like peptide 1 was calculated. The mean age (SD) was 55.1 (8.3) years and median (interquartile range) haemoglobin A1c was 5.97% (5.86, 6.23). There was no relationship between sleep duration or efficiency and fasting or area under the curve glucagon‐like peptide 1. Glucagon‐like peptide 1 levels did not differ among those sleeping ≤ 5.75, > 5.75–< 6.5 or ≥ 6.5 h per night. Increasing apnea–hypopnea index, an indicator of obstructive sleep apnea severity, correlated with lower area under the curve glucagon‐like peptide 1 (B −0.242, P = 0.045), but not with fasting glucagon‐like peptide 1 (B −0.213, P = 0.079). After adjusting for sex, haemoglobin A1c and body mass index, increasing apnea–hypopnea index was negatively associated with having area under the curve glucagon‐like peptide 1 in the highest quartile (odds ratio 0.581, P = 0.028, 95% CI 0.359, 0.942). This study demonstrated that increasing obstructive sleep apnea severity was associated with lower glucagon‐like peptide 1 response to glucose challenge. This could possibly be an additional mechanism by which obstructive sleep apnea affects glucose metabolism. Whether raising glucagon‐like peptide 1 levels in patients with abnormal glucose tolerance with more severe obstructive sleep apnea will be beneficial should be explored.
Title: The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance
Description:
SummaryGlucagon‐like peptide 1 plays a role in glucose regulation.
Sleep disturbances (obstructive sleep apnea, insufficient or poor sleep quality) have been shown to adversely affect glucose metabolism.
This study aimed to explore the relationship between sleep and glucagon‐like peptide 1 regulation in patients with abnormal glucose tolerance.
Seventy‐one adults with haemoglobin A1c levels between 5.
7% and < 6.
5% and no history of diabetes participated.
Habitual sleep duration and efficiency were obtained from 7‐day actigraphy recordings.
Obstructive sleep apnea was assessed using an overnight home monitor.
Glucagon‐like peptide 1 levels were measured during a 75‐g glucose tolerance.
The area under the curve of glucagon‐like peptide 1 was calculated.
The mean age (SD) was 55.
1 (8.
3) years and median (interquartile range) haemoglobin A1c was 5.
97% (5.
86, 6.
23).
There was no relationship between sleep duration or efficiency and fasting or area under the curve glucagon‐like peptide 1.
Glucagon‐like peptide 1 levels did not differ among those sleeping ≤ 5.
75, > 5.
75–< 6.
5 or ≥ 6.
5 h per night.
Increasing apnea–hypopnea index, an indicator of obstructive sleep apnea severity, correlated with lower area under the curve glucagon‐like peptide 1 (B −0.
242, P = 0.
045), but not with fasting glucagon‐like peptide 1 (B −0.
213, P = 0.
079).
After adjusting for sex, haemoglobin A1c and body mass index, increasing apnea–hypopnea index was negatively associated with having area under the curve glucagon‐like peptide 1 in the highest quartile (odds ratio 0.
581, P = 0.
028, 95% CI 0.
359, 0.
942).
This study demonstrated that increasing obstructive sleep apnea severity was associated with lower glucagon‐like peptide 1 response to glucose challenge.
This could possibly be an additional mechanism by which obstructive sleep apnea affects glucose metabolism.
Whether raising glucagon‐like peptide 1 levels in patients with abnormal glucose tolerance with more severe obstructive sleep apnea will be beneficial should be explored.

Related Results

Postprandial Glucagon Action in the Human Brain
Postprandial Glucagon Action in the Human Brain
ABSTRACT Aims Elevated fasting glucagon is linked to hyperglycemia, but postprandial glucagon effects are less understood...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract Introduction During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
34-OR: Postprandial Glucagon Action in the Human Brain
34-OR: Postprandial Glucagon Action in the Human Brain
While elevated fasting glucagon is linked to hyperglycemia, the impact of postprandial changes in glucagon is less clear. Recent findings suggest potential metabolic benefits of ri...
Acupuncture as therapeutic resource in patient with bruxism
Acupuncture as therapeutic resource in patient with bruxism
Bruxism is the harmful habit of clenching or grinding the teeth during the day and / or night, with unconscious pattern, with particular intensity and frequency, outside the functi...
Glucagon and Its Receptors in the Mammalian Heart
Glucagon and Its Receptors in the Mammalian Heart
Glucagon exerts effects on the mammalian heart. These effects include alterations in the force of contraction, beating rate, and changes in the cardiac conduction system axis. The ...
62-OR: Evidence of Gut-Derived Glucagon in Man
62-OR: Evidence of Gut-Derived Glucagon in Man
We have previously shown that totally pancreatectomized patients (PX) and patients with type 2 diabetes (T2D) exhibit hypersecretion of glucagon in response to oral glucose stimula...
Paradoxical stimulation of glucagon secretion by high glucose concentrations
Paradoxical stimulation of glucagon secretion by high glucose concentrations
Hypersecretion of glucagon contributes to the dysregulation of glucose homeostasis in diabetes. To clarify the underlying mechanism, glucose-regulated glucagon secretion was studie...
Glucoregulatory Mechanisms Following Hypophysectomy in Diabetic Dogs with Residual Insulin Secretion
Glucoregulatory Mechanisms Following Hypophysectomy in Diabetic Dogs with Residual Insulin Secretion
It is known that in pancreatectomized dogs completely deprived of insulin, hypophysectomy normalizes plasma glucagon and prevents ketoacidosis, but rarely normalizes glucose levels...

Back to Top